Associated Papers
Matrin-3 forms spherical and wormlike assemblies that are modulated by RNA binding and ALS/FTD-associated mutations.
Sprunger ML et al.
Molecular Cell, 2025
The role of Matrin-3 in physiology and its dysregulation in disease.
Sprunger ML et al.
Biochemical Society Transactions, 2024
MATR3's Role beyond the Nuclear Matrix: From Gene Regulation to Its Implications in Amyotrophic Lateral Sclerosis and Other Diseases.
Santos JR et al.
Cells, 2024
MATR3-antisense LINE1 RNA meshwork scaffolds higher-order chromatin organization.
Zhang Y et al.
Embo Reports, 2023
37381832 (PubMed )
Supplement: EMBR-24-e57550-s003.pdf
Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants.
McCann EP et al.
Journal of Neuromuscular Diseases, 2023
37638449 (PubMed )
Supplement: jnd-10-jnd230148-s001.xlsx › variant_list
Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Malik AM et al.
Jci Insight, 2021
Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization.
Malik AM et al.
Elife, 2018
ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export.
Boehringer A et al.
Scientific Reports, 2017
Matrin 3 variants are frequent in Italian ALS patients.
Marangi G et al.
Neurobiology of Aging, 2017
Amyotrophic lateral sclerosis: recent genetic highlights.
White MA et al.
Current Opinion in Neurology, 2016
New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis.
Sabatelli M et al.
Brain Pathology (zurich, Switzerland), 2016
Genotype-phenotype correlations of amyotrophic lateral sclerosis.
Li HF et al.
Translational Neurodegeneration, 2016
Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis.
Lin KP et al.
Neurobiology of Aging, 2015
Select a paper to view details